Beyond the conventional focus on amyloid protein and tau pathology, researchers are increasingly identifying new therapeutic areas for Alzheimer's illness. These include affecting neuroinflammation through reducing glial activation, modifying neuronal loss – particularly associated with excitatory neurotransmitter communication – and assessing